Shares of Evoke plc (LON:EVOK – Get Free Report) were down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
Several brokerages recently weighed in on EVOK. Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank reduced their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th.
Read Our Latest Stock Analysis on EVOK
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Sell-side analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Buying and Selling at Evoke
In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
About Evoke
Featured Stories
- Five stocks we like better than Evoke
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 03/24 – 03/28
- Short Selling: How to Short a Stock
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Short Nasdaq: An Easy-to-Follow Guide
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.